Palisade Bio, Inc. (PALI)

Palisade Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-12.32	-14.55	-26.62	-10.32	-8.35
Depreciation & Amortization	0.11	0.17	0.17	0.15	0.14
Share-Based Compensation	0.62	1.03	1.89	2.01	0.88
Other Operating Activities	0.45	-0.01	9.78	3.39	0.07
Operating Cash Flow	-11.13	-13.36	-14.77	-4.77	-7.26
Capital Expenditures	-0	-0.01	0	-0.01	0
Acquisitions	0	0	3.28	0	0
Other Investing Activities	-	-	-3.33	-	-
Investing Cash Flow	-0	-0.01	-0.05	-0.01	0
Share Issuance / Repurchase	11.58	16.05	5.14	1.18	6.55
Debt Issued / Paid	-0.39	-0.79	-0.33	0.72	0.04
Other Financing Activities	-	-	19.8	-	-
Financing Cash Flow	11.19	15.26	24.61	1.89	6.59
Exchange Rate Effect	0	0	0	0	-0.01
Net Cash Flow	0.05	1.89	9.78	-2.88	-0.67
Free Cash Flow	-11.14	-13.37	-14.77	-4.77	-7.26
Free Cash Flow Margin	-4454.80%	-	-	-	-47133.17%
Free Cash Flow Per Share	-24.42	-227.82	-1190.12	-1290.56	-14858.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).